Blackstone’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$407K Buy
+7,405
New +$303K ﹤0.01% 394

Other funds holding TGTX

Blackstone's TGTX Position: Q2 2026 in Review

Blackstone opened a new position in TG Therapeutics (TGTX) in Q2 2026: 7,405 shares worth $407K. The stake represents ﹤0.01% of the portfolio and ranks #394 among its holdings.

434 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Blackstone held 7,405 shares of TG Therapeutics worth $407K as of Q2 2026.
  • TG Therapeutics was a new Blackstone position in Q2 2026.
  • TG Therapeutics made up ﹤0.01% of Blackstone's portfolio in Q2 2026, its #394 holding.
  • 434 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.